Resmed (RSMDF) Free Cash Flow (2009 - 2026)

Resmed has reported Free Cash Flow for 18 years, with the latest figure at $520.5 million in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 6.7% year-over-year to $520.5 million; the trailing twelve-month figure through Mar 2026 stood at $1.8 billion (up 11.82% YoY), and the FY2025 full-year result was $1.7 billion, up 27.65% from the prior year.
• Free Cash Flow for Q1 2026 stood at $520.5 million, up from $311.2 million in the prior quarter.
• The five-year high for Free Cash Flow was $557.9 million in Q1 2025, with the low at $15.6 million in Q3 2022.
• Historically, Free Cash Flow has averaged $288.4 million across 5 years, with a median of $288.0 million in 2024.
• Annual changes were most pronounced in 2022 — Free Cash Flow plunged 74.4% — and 2023, when it jumped 1541.98%.
• Resmed's Free Cash Flow stood at $101.3 million in 2022, then soared by 146.31% to $249.5 million in 2023, then increased by 15.43% to $288.0 million in 2024, then grew by 8.07% to $311.2 million in 2025, then soared by 67.25% to $520.5 million in 2026.
• The last three Free Cash Flow figures came in at $520.5 million (Q1 2026), $311.2 million (Q4 2025), and $414.4 million (Q3 2025), per Business Quant data.